Literature DB >> 2060774

Homology requirements for unequal crossing over in humans.

A B Metzenberg1, G Wurzer, T H Huisman, O Smithies.   

Abstract

To gain insight into mechanisms of unequal homologous recombination in vivo, genes generated by homologous unequal crossovers in the human beta-globin gene cluster were examined by nucleotide sequencing and hybridization experiments. The naturally occurring genes studied included one delta-beta Lepore-Baltimore fusion gene, one delta-beta Lepore-Hollandia fusion gene, 12 delta-beta Lepore-Boston genes, one A gamma-beta fusion Kenya gene, one A gamma-G gamma fusion (the central gene of a triplication) and one G gamma-A gamma fusion. A comparison of the nucleotide sequences of three Lepore-Boston genes indicates that they were derived from at least two independent homologous but unequal crossover events, although the crossovers occurred within the same 58-bp region. Nine additional Lepore-Boston genes from individuals of various ethnic origins were shown, by hybridization to specific oligonucleotide probes, to have been generated by a crossover in the same region as the sequenced genes. Evidence for gene conversion accompanying a homologous unequal crossover event was found in only one case (although some of the single nucleotide differences observed in other genes in this study may be related to the crossover events in ways that we do not presently understand). Thus, as judged by this limited sample, concurrent gene conversions are not commonly associated with homologous but unequal exchange in humans in vivo. Classification of the recombinant chromosomes by their polymorphic restriction sites in the beta-globin gene cluster indicated that the Lepore-Boston genes are found in at least six different haplotype backgrounds. Therefore the total number of independent examples in this study is at least 6, and at most 12. We have shown that in at least six cases of genes that have arisen by homologous but unequal crossing over in vivo, each event occurred in a relatively extensive region of uninterrupted identity between the parental genes. This preference cannot be explained by a mechanism whereby crossovers occur at random within misaligned related but not identical genes. In general, crossovers occur in regions that are among the largest available stretches of identity for a particular pair of mismatched genes. Our data are in agreement with those of other types of studies of homologous recombination, and support the idea that sequence identity, rather than general homology, is a critical factor in homologous recombination.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060774      PMCID: PMC1204444     

Source DB:  PubMed          Journal:  Genetics        ISSN: 0016-6731            Impact factor:   4.562


  90 in total

1.  Unexpected relationships between four large deletions in the human beta-globin gene cluster.

Authors:  E F Vanin; P S Henthorn; D Kioussis; F Grosveld; O Smithies
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

2.  Gene deletion as the molecular basis for the Kenya-G gamma-HPFH condition.

Authors:  P J Ojwang; T Nakatsuji; M B Gardiner; A L Reese; J G Gilman; T H Huisman
Journal:  Hemoglobin       Date:  1983       Impact factor: 0.849

3.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

4.  S1-nuclease mapping of the genomic Lepore-Boston DNA demonstrates that the entire large intervening sequence of the fusion gene is of beta-type.

Authors:  Y Chebloune; D Poncet; G Verdier
Journal:  Biochem Biophys Res Commun       Date:  1984-04-16       Impact factor: 3.575

5.  Boundaries of gene conversion within the duplicated human alpha-globin genes. Concerted evolution by segmental recombination.

Authors:  A M Michelson; S H Orkin
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

6.  Origin of the beta S-globin gene in blacks: the contribution of recurrent mutation or gene conversion or both.

Authors:  S E Antonarakis; C D Boehm; G R Serjeant; C E Theisen; G J Dover; H H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

7.  A fusion gene in man: DNA sequence analysis of the abnormal globin gene of hemoglobin Miyada.

Authors:  A Kimura; Y Ohta; Y Fukumaki; Y Takagi
Journal:  Biochem Biophys Res Commun       Date:  1984-03-30       Impact factor: 3.575

8.  Human fetal globin DNA sequences suggest novel conversion event.

Authors:  C J Stoeckert; F S Collins; S M Weissman
Journal:  Nucleic Acids Res       Date:  1984-06-11       Impact factor: 16.971

9.  Insertions, deletions and mismatches in heteroduplex DNA made by recA protein.

Authors:  M E Bianchi; C M Radding
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

10.  Molecular characterization of seven beta-thalassemia mutations in Asian Indians.

Authors:  H H Kazazian; S H Orkin; S E Antonarakis; J P Sexton; C D Boehm; S C Goff; P G Waber
Journal:  EMBO J       Date:  1984-03       Impact factor: 11.598

View more
  33 in total

1.  Characterization of Alu and recombination-associated motifs mediating a large homozygous SPG7 gene rearrangement causing hereditary spastic paraplegia.

Authors:  Eva López; Carlos Casasnovas; Javier Giménez; Antoni Matilla-Dueñas; Ivelisse Sánchez; Víctor Volpini
Journal:  Neurogenetics       Date:  2014-11-16       Impact factor: 2.660

2.  A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease.

Authors:  A Görlach; P L Lee; J Roesler; P J Hopkins; B Christensen; E D Green; S J Chanock; J T Curnutte
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Synaptonemal complexes from DNase-treated rat pachytene chromosomes contain (GT)n and LINE/SINE sequences.

Authors:  R E Pearlman; N Tsao; P B Moens
Journal:  Genetics       Date:  1992-04       Impact factor: 4.562

4.  The Alu-rich genomic architecture of SPAST predisposes to diverse and functionally distinct disease-associated CNV alleles.

Authors:  Philip M Boone; Bo Yuan; Ian M Campbell; Jennifer C Scull; Marjorie A Withers; Brett C Baggett; Christine R Beck; Christine J Shaw; Pawel Stankiewicz; Paolo Moretti; Wendy E Goodwin; Nichole Hein; John K Fink; Moon-Woo Seong; Soo Hyun Seo; Sung Sup Park; Izabela D Karbassi; Sat Dev Batish; Andrés Ordóñez-Ugalde; Beatriz Quintáns; María-Jesús Sobrido; Susanne Stemmler; James R Lupski
Journal:  Am J Hum Genet       Date:  2014-07-24       Impact factor: 11.025

5.  The extent, mechanism, and consequences of genetic variation, for recombination rate.

Authors:  W P Robinson
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

6.  Unequal homologous recombination of human DNA on a yeast artificial chromosome.

Authors:  C Campbell; I Marondel; K Montgomery; K Krauter; R Kucherlapati
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

7.  Nonrandom localization of recombination events in human alpha satellite repeat unit variants: implications for higher-order structural characteristics within centromeric heterochromatin.

Authors:  P E Warburton; J S Waye; H F Willard
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

8.  Evolution of a repeat sequence in the parathyroid hormone-related peptide gene in primates.

Authors:  Z Pausova; K Morgan; T M Fujiwara; G N Hendy
Journal:  Mamm Genome       Date:  1995-06       Impact factor: 2.957

9.  New genes originated via multiple recombinational pathways in the beta-globin gene family of rodents.

Authors:  Federico G Hoffmann; Juan C Opazo; Jay F Storz
Journal:  Mol Biol Evol       Date:  2008-09-09       Impact factor: 16.240

10.  Mutations in the VNTR of the carboxyl-ester lipase gene (CEL) are a rare cause of monogenic diabetes.

Authors:  Janniche Torsvik; Stefan Johansson; Anders Johansen; Jakob Ek; Jayne Minton; Helge Raeder; Sian Ellard; Andrew Hattersley; Oluf Pedersen; Torben Hansen; Anders Molven; Pål R Njølstad
Journal:  Hum Genet       Date:  2009-09-17       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.